Rafal Iwasiow
Sample Management Solutions R&D & Chief ScientistMr. Rafal Iwasiow, Ph.D., is Sample Management Solutions R&D & Chief Scientist of OraSure Technologies, Inc. from 2025. He was Vice President of Science, Innovation & Technology of OraSure Technologies, Inc. from 2023 until 2025. He serves as Vice President of Research & Development of DNA Genotek, Inc. Dr. Iwasiow joined DNA Genotek in 2006 as a Research & Development Scientist; he has contributed significantly to the company's patent portfolio in numerous areas including nucleic acid stabilization methods and physical sample collection devices. In 2008 he took on the responsibility of managing the product development team and has advanced his career through Director level roles resulting in his appointment to the Vice President of Research and Development. Under Dr. Iwasiow’s leadership, the Research and Development team contributed to successful 510(k) clearances of the Oragene•Dx collection device, the first non-invasive DNA collection device cleared by the FDA and he and his team have developed and delivered new chemistries, products and service offerings throughout with the company. Dr. Iwasiow completed a post-doctoral fellowship at the National Research Council of Canada in the areas of neurogenesis/neuroprotection and he holds a Ph.D. degree in Cellular and Molecular Medicine from the University of Ottawa.
Positions
- Company NameOraSure Technologies, Inc.Stock CodeOSURPositionSample Management Solutions R&D & Chief ScientistColleagues
- CECarrie Eglinton MannerPresident, CEO & Director
- JPJohn Patrick KennyIndependent Chairman
- KJKenneth J. McGrathChief Financial Officer
- MAMichele AnthonySenior VP, Chief Accounting Officer, Controller & Assistant Secretary
- KDKaren DaviesDiagnostics R&D & Chief Technologist
- NJNancy J. GaglianoIndependent Director
- RWRobert W. McMahonIndependent Director
- LMLelio MarmoraIndependent Director
